Publicaciones en las que colabora con Juan García de Lomas (33)

2006

  1. Type-specific antibodies to pneumococcal capsular polysaccharide acquired either naturally or after vaccination with prevenar in children with underlying chronic or recurrent lung diseases

    Clinical and Vaccine Immunology, Vol. 13, Núm. 6, pp. 665-670

2004

  1. Performance of the binax NOW Streptococcus pneumoniae urinary antigen assay for diagnosis of pneumonia in children with underlying pulmonary diseases in the absence of acute pneumococcal infection

    Journal of Clinical Microbiology, Vol. 42, Núm. 10, pp. 4853-4855

2002

  1. Activities of six different quinolones against clinical respiratory isolates of streptococcus pneumoniae with reduced susceptibility to ciprofloxacin in Spain

    Antimicrobial Agents and Chemotherapy, Vol. 46, Núm. 8, pp. 2665-2667

  2. Activity of six quinolones against 226 recent clinical isolates of Streptococcus pyogenes with reduced susceptibility to ciprofloxacin [3]

    Journal of Antimicrobial Chemotherapy

  3. Susceptibility patterns of bacteria causing community-acquired respiratory infections in Spain: The SAUCE project

    Journal of Antimicrobial Chemotherapy, Vol. 50, Núm. SUPPL. 2, pp. 21-26

2001

  1. Antimicrobial susceptibilities of 1,730 Haemophilus influenzae respiratory tract isolates in Spain in 1998-1999

    Antimicrobial Agents and Chemotherapy, Vol. 45, Núm. 11, pp. 3226-3228

1999

  1. Acreditacion y certificacion de laboratorios de microbiologia clinica? Si, pero son adecuados ENAC y AENOR?

    Enfermedades Infecciosas y Microbiologia Clinica

1998

  1. A comparative study on the efficacy of the new quinolone alatrofloxacin in the treatment of experimental legionellosis in guinea pigs

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 17, Núm. 6, pp. 420-423

  2. In vitro interaction between ofloxacin and cefotaxime against gram-positive and gram-negative bacteria involved in serious infections

    Chemotherapy, Vol. 44, Núm. 2, pp. 94-98

1997

  1. Antimicrobial susceptibility of Streptococcus pneumoniae isolated from pediatric carriers in Spain

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 16, Núm. 1, pp. 11-13

  2. Meningitis por Haemophilus influenzae no serotipificable biotipo V [2]

    Enfermedades Infecciosas y Microbiologia Clinica

  3. Penetracion de meropenem en bacilos gramnegativos. Diferencias de actividad con imipenem

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 15, Núm. SUPPL. 1, pp. 14-19

  4. Susceptibility of pseudomonas aeruginosa isolates to ceftazidime is unrelated to the expression of the outer membrane protein OprC

    Chemotherapy, Vol. 43, Núm. 1, pp. 27-30

1996

  1. Actividad de eritromicina y claritromicina frente a aislados de Streptococcus pneumoniae con sensibilidad disminuida a la penicilina obtenidos de portadores sanos

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 14, Núm. 7, pp. 422-425

  2. Meropenem permeation through the outer membrane of pseudomonas aeruginosa can involve pathways other than the oprd porin channel

    Chemotherapy, Vol. 42, Núm. 3, pp. 210-214

  3. Relationship between Outer Membrane Protein Profiles and Resistance to Ceftazidime, Imipenem, and Ciprofloxacin in Pseudomonas aeruginosa Isolates from Bacteremic Patients

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 15, Núm. 1, pp. 82-85

1995

  1. Multicentre comparative study on the antibacterial activity of FK-037, a new parenteral cephalosporin

    European Journal of Clinical Microbiology & Infectious Diseases, Vol. 14, Núm. 3, pp. 244-252

  2. Rapid diagnosis of pleural tuberculosis by polymerase chain reaction

    American Journal of Respiratory and Critical Care Medicine, Vol. 152, Núm. 6 I, pp. 1977-1981

  3. The utility of polymerase chain reaction (PCR) in the diagnosis of pulmonary tuberculosis

    Chest, Vol. 107, Núm. 6, pp. 1631-1635

1994

  1. MODELOS EXPERIMENTALES IN VIVO PARA EVALUAR PAUTAS TERAPEUTICAS FRENTE A NEUMONIAS PRO LEGIONELLA SP.

    Revista Espanola de Quimioterapia, Vol. 7, Núm. 1, pp. 32-38